Gene‐based SNP mapping of a psychotic bipolar affective disorder linkage region on 22q12.3: Association with HMG2L1 and TOM1

Genetic linkage studies in both bipolar affective disorder (BPAD) and schizophrenia have implicated overlapping regions of chromosome 22q. We previously reported that BPAD pedigrees containing multiple members with psychotic symptoms showed suggestive linkage to chromosome 22q12.3. Now we have tested 189 single nucleotide polymorphisms (SNPs) spanning a 3 Mb region around the linkage peak for association with BPAD in 305 families, unrelated cases, and controls. SNPs were selected in or near genes, resulting in coverage at a density of 1 SNP per 6.7 kb across the 22 annotated genes in the region. The strongest signal emerged from family‐based association analysis of an 11‐SNP, 54 kb haplotype straddling the gene HMG2L1 and part of TOM1. A 3‐marker haplotype of SNPs within TOM1 was associated with BPAD (allele‐wise P = 0.0011) and with psychotic BPAD (allele‐wise P = 0.00049). As hypothesized, the mean odds ratio for the risk alleles across the region was 1.39 in the psychotic but only 0.96 in the non‐psychotic subset. Genotype‐wise analyses yielded similar results, but the psychotic/non‐psychotic distinction was more pronounced with mean odds ratios of 1.91 versus 0.8. Permutation of genotype‐wise results for rs2413338 in HMG2L1 showed an empirical P = 0.037 for the difference between subsets. HMG2L1 is a negative regulator of Wnt signaling, a pathway of interest in psychotic BPAD as it is activated by both mood stabilizer and anti‐psychotic medications. Further work is needed to confirm these results and uncover the functional variation underlying the association signal. © 2007 Wiley‐Liss, Inc.

[1]  T. Sotnikova,et al.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Leboyer,et al.  Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. , 2003, The American journal of psychiatry.

[3]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[4]  C. Dion,et al.  A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes , 2001, Molecular Psychiatry.

[5]  M. Matsuura,et al.  Mutation screening and association study of the beta-adrenergic receptor kinase 2 gene in schizophrenia families , 2004, Psychiatry Research.

[6]  U. Kang,et al.  The effects of clozapine on the GSK‐3‐mediated signaling pathway , 2004, FEBS letters.

[7]  A. Serretti,et al.  A single nucleotide polymorphism in glycogen synthase kinase 3-β promoter gene influences onset of illness in patients affected by bipolar disorder , 2004, Neuroscience Letters.

[8]  K Y Liang,et al.  A Robust Identity-by-Descent Procedure Using Affected Sib Pairs: Multipoint Mapping for Complex Diseases , 2000, Human Heredity.

[9]  Maria Karayiorgou,et al.  Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia , 2004, Nature Genetics.

[10]  John P. Rice,et al.  Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. , 1997, American journal of medical genetics.

[11]  H. Herken,et al.  Research Paper Mediators of Inflammation, 10, 109–115 (2001) ACTIVAT ION of the inflammatory response system and , 2022 .

[12]  D. Clayton,et al.  A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. , 2002, American journal of human genetics.

[13]  R. Yolken,et al.  Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder , 2001, British Journal of Psychiatry.

[14]  Abraham Weizman,et al.  COMT: A common susceptibility gene in bipolar disorder and schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[15]  D. Housman,et al.  Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. , 1994, American journal of medical genetics.

[16]  N. Craddock,et al.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis , 2005, Journal of Medical Genetics.

[17]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[18]  G D Pearlson,et al.  The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. , 2001, The American journal of psychiatry.

[19]  C. Stefanis,et al.  Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients , 2001, Schizophrenia Research.

[20]  R. Straub,et al.  Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: A family based association study , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  A. Frances.  The Diagnostic Interview for Genetic Studies , 1994 .

[22]  H. Yokosawa,et al.  Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1- and tumor necrosis factor-induced signaling pathways. , 2004, Biological & pharmaceutical bulletin.

[23]  J. Kelsoe,et al.  Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder , 2003, Molecular Psychiatry.

[24]  M A Spence,et al.  A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Gershon,et al.  Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.

[27]  J. Nurnberger,et al.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.

[28]  W. Berrettini,et al.  Are schizophrenic and bipolar disorders related? A review of family and molecular studies , 2000, Biological Psychiatry.

[29]  Marvin J. Miller,et al.  Genomic Survey of Bipolar Illness in the NIMH Genetics Initiative Pedigrees: A Preliminary Report , 1997 .

[30]  Hiroshi Shibuya,et al.  Negative regulation of Wnt signalling by HMG2L1, a novel NLK‐binding protein , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  H. Manji,et al.  The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3 , 2000, Journal of neurochemistry.

[32]  Peter B. Jones,et al.  Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Xin Xu,et al.  Implementing a unified approach to family‐based tests of association , 2000, Genetic epidemiology.

[34]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[35]  E. Paykel,et al.  Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. , 2000, American journal of medical genetics.

[36]  P. Visscher,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.

[37]  F. McMahon,et al.  Familial aggregation of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[38]  Laura J. Bierut,et al.  Genomic survey of bipolar illness in the NIMH genetics initiative pedigrees: a preliminary report. , 1996, American journal of medical genetics.

[39]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Detera-Wadleigh,et al.  Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study , 2003, Neuroscience Letters.

[41]  S. Cichon,et al.  Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin , 2004, Nature Genetics.

[42]  J. Smoller,et al.  Family, twin, and adoption studies of bipolar disorder , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[43]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[44]  Monika Milewski,et al.  Decoding randomly ordered DNA arrays. , 2004, Genome research.

[45]  J. Nurnberger,et al.  A Bipolar Pedigree Series for Genomic Mapping of Disease Genes: Diagnostic and Analytic Considerations , 1991 .

[46]  Francis J McMahon,et al.  Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. , 2003, The American journal of psychiatry.

[47]  Lon R. Cardon,et al.  GRR: graphical representation of relationship errors , 2001, Bioinform..

[48]  G. Kirov,et al.  Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[49]  D. Housman,et al.  Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes , 2000, Molecular Psychiatry.

[50]  J. Cooper,et al.  Reliability of a Procedure for Measuring and Classifying “Present Psychiatric State” , 1967, British Journal of Psychiatry.

[51]  S. Nanko,et al.  Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder , 2003, Nature Genetics.

[52]  R. Kucherlapati,et al.  Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. , 1997, American journal of human genetics.

[53]  M. Daly,et al.  Genome-wide scan in Portuguese Island families identifies 5q31–5q35 as a susceptibility locus for schizophrenia and psychosis , 2004, Molecular Psychiatry.

[54]  High Rates of Schizophrenia in Adults With Velo-Cardio-Facial Syndrome , 1999 .

[55]  L R Goldin,et al.  A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Duan,et al.  A case-control study provides evidence of association for a functional polymorphism -197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect. , 2004, Biochemical and biophysical research communications.

[57]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[58]  G. Kirov,et al.  Sibling pairs with affective disorders: resemblance of demographic and clinical features , 2002, Psychological Medicine.

[59]  Lon R. Cardon,et al.  A first-generation linkage disequilibrium map of human chromosome 22 , 2002, Nature.

[60]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[61]  S. Faraone,et al.  Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. , 2003, The American journal of psychiatry.

[62]  R. Murray,et al.  A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). , 1996, American journal of medical genetics.

[63]  M. Weissman,et al.  Affective disorders in five United States communities , 1988, Psychological Medicine.

[64]  Christoph Lange,et al.  Power calculations for a general class of family-based association tests: dichotomous traits. , 2002, American journal of human genetics.

[65]  S. Folstein,et al.  Assessment of lineality in bipolar I linkage studies. , 1992, The American journal of psychiatry.